Literature DB >> 30041133

The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis.

Tania Lecomte1, Alexandre Dumais2, Jules R Dugré3, Stéphane Potvin4.   

Abstract

There is little consensus regarding the prevalence of methamphetamine-induced psychotic disorder (MIPD). A search of the literature was performed, effect size estimates were calculated with event rates and were aggregated with a random-effects model. Seventeen studies were included in the meta-analysis, resulting in a composite event rate of 36.5%. The event rate of MIPD was significantly higher when the period of assessment was lifetime (42.7%) and when only individuals with methamphetamine use disorders (MUD) (43.3%) were included. The prevalence of MIPD in the reviewed studies is elevated. These results highlight the need for detection and prevention strategies, and population studies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Meta-analysis; Methamphetamine; Psychosis

Mesh:

Substances:

Year:  2018        PMID: 30041133     DOI: 10.1016/j.psychres.2018.05.033

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Assessing the mediating role of impulsivity between methamphetamine-induced psychotic disorders and increased gambling severity in methamphetamine-dependent individuals.

Authors:  Huixi Dong; Yidong Shen; Wei Hao
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-08-16       Impact factor: 5.760

2.  Dopamine manipulations modulate paranoid social inferences in healthy people.

Authors:  J M Barnby; V Bell; Q Deeley; M A Mehta
Journal:  Transl Psychiatry       Date:  2020-07-05       Impact factor: 6.222

3.  Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Benjamin Murrie; Julia Lappin; Matthew Large; Grant Sara
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

4.  Antipsychotics for Amphetamine Psychosis. A Systematic Review.

Authors:  Dimy Fluyau; Paroma Mitra; Kervens Lorthe
Journal:  Front Psychiatry       Date:  2019-10-15       Impact factor: 4.157

5.  Intestinal mRNA expression profile and bioinformatics analysis in a methamphetamine-induced mouse model of inflammatory bowel disease.

Authors:  Jiaxue Sun; Fengrong Chen; Cheng Chen; Zherui Zhang; Zunyue Zhang; Weiwei Tian; Juehua Yu; Kunhua Wang
Journal:  Ann Transl Med       Date:  2020-12

Review 6.  Substance-Induced Psychoses: An Updated Literature Review.

Authors:  Alessio Fiorentini; Filippo Cantù; Camilla Crisanti; Guido Cereda; Lucio Oldani; Paolo Brambilla
Journal:  Front Psychiatry       Date:  2021-12-23       Impact factor: 4.157

Review 7.  Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Authors:  Alexandre A Guerin; Eric J Nestler; Michael Berk; Andrew J Lawrence; Susan L Rossell; Jee Hyun Kim
Journal:  Neurosci Biobehav Rev       Date:  2020-11-17       Impact factor: 8.989

8.  Epidemiological Characteristics and Risk Factors of Methamphetamine-Associated Psychotic Symptoms.

Authors:  Meng-Fan Su; Mo-Xuan Liu; Jin-Qiao Li; Julia M Lappin; Su-Xia Li; Ping Wu; Zhi-Min Liu; Jie Shi; Lin Lu; Yanping Bao
Journal:  Front Psychiatry       Date:  2018-10-12       Impact factor: 4.157

Review 9.  A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology.

Authors:  Travis A Wearne; Jennifer L Cornish
Journal:  Front Psychiatry       Date:  2018-10-10       Impact factor: 4.157

Review 10.  [Differential diagnostic distinction between substance-induced and primary psychoses: : Recommendations for general psychiatric and forensic practice].

Authors:  Dusan Hirjak; Andreas Meyer-Lindenberg; Geva A Brandt; Harald Dreßing
Journal:  Nervenarzt       Date:  2021-03-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.